Jointown Pharmaceutical Group Co., Ltd (SHA:600998)
China
· Delayed Price · Currency is CNY 5.19
+0.04 (0.78%)
Apr 29, 2026, 3:00 PM CST
SHA:600998 Revenue
Jointown Pharmaceutical Group had revenue of 44.78B CNY in the quarter ending March 31, 2026, with 6.58% growth. This brings the company's revenue in the last twelve months to 164.16B, up 7.04% year-over-year. In the year 2025, Jointown Pharmaceutical Group had annual revenue of 161.39B with 6.31% growth.
Revenue (ttm)
164.16B
Revenue Growth
+7.04%
P/S Ratio
0.16
Revenue / Employee
5.44M
Employees
30,169
Market Cap
25.68B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 161.39B | 9.58B | 6.31% |
| Dec 31, 2024 | 151.81B | 1.67B | 1.11% |
| Dec 31, 2023 | 150.14B | 9.72B | 6.92% |
| Dec 31, 2022 | 140.42B | 18.02B | 14.72% |
| Dec 31, 2021 | 122.41B | 11.55B | 10.42% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| China National Medicines Corporation | 53.31B |
| Guangzhou Baiyunshan Pharmaceutical Holdings Company | 77.66B |
| Liaoning Cheng Da | 9.90B |
| China Meheco Group | 35.36B |
| Qingdao Baheal Medical INC. | 7.58B |
| China National Accord Medicines Corporation | 72.95B |
| Shanghai Pharmaceuticals Holding | 283.58B |
| C.Q. Pharmaceutical Holding | 82.27B |